| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Cyclin B1/CDK1-regulated mitochondrial bioenergetics in cell cycle progression and tumor resistance
|
Xie, Bowen
|
|
2019
|
443 |
C |
p. 56-66
|
artikel
|
| 2 |
Editorial Board
|
|
|
2019
|
443 |
C |
p. ii
|
artikel
|
| 3 |
Gankyrin drives metabolic reprogramming to promote tumorigenesis, metastasis and drug resistance through activating β-catenin/c-Myc signaling in human hepatocellular carcinoma
|
Liu, Ruiqi
|
|
2019
|
443 |
C |
p. 34-46
|
artikel
|
| 4 |
HBV induces different responses of the hepatocytes and oval cells during HBV-related hepatic cirrhosis
|
Zhang, Lei
|
|
2019
|
443 |
C |
p. 47-55
|
artikel
|
| 5 |
Inhibition of tankyrase by a novel small molecule significantly attenuates prostate cancer cell proliferation
|
Cheng, Honglin
|
|
2019
|
443 |
C |
p. 80-90
|
artikel
|
| 6 |
Isolinderalactone regulates the BCL-2/caspase-3/PARP pathway and suppresses tumor growth in a human glioblastoma multiforme xenograft mouse model
|
Hwang, Ji Young
|
|
2019
|
443 |
C |
p. 25-33
|
artikel
|
| 7 |
Melatonin inhibits MLL-rearranged leukemia via RBFOX3/hTERT and NF-κB/COX-2 signaling pathways
|
Tang, Yan-Lai
|
|
2019
|
443 |
C |
p. 167-178
|
artikel
|
| 8 |
MicroRNA-371a-3p promotes progression of gastric cancer by targeting TOB1
|
Guo, Hai
|
|
2019
|
443 |
C |
p. 179-188
|
artikel
|
| 9 |
MicroRNA-146b-5p as an oncomiR promotes papillary thyroid carcinoma development by targeting CCDC6
|
Jia, Meng
|
|
2019
|
443 |
C |
p. 145-156
|
artikel
|
| 10 |
Non-platelet-derived CXCL4 differentially regulates cytotoxic and regulatory T cells through CXCR3 to suppress the immune response to colon cancer
|
Deng, Shaorong
|
|
2019
|
443 |
C |
p. 1-12
|
artikel
|
| 11 |
Novel flexible heteroarotinoid, SL-1-39, inhibits HER2-positive breast cancer cell proliferation by promoting lysosomal degradation of HER2
|
Zou, Hongye
|
|
2019
|
443 |
C |
p. 157-166
|
artikel
|
| 12 |
Oncogene addiction as a foundation of targeted cancer therapy: The paradigm of the MET receptor tyrosine kinase
|
Orlando, Eleonora
|
|
2019
|
443 |
C |
p. 189-202
|
artikel
|
| 13 |
Phosphatidyl inositol 3-kinase (PI3K)-mTOR inhibitor PKI-402 inhibits breast cancer induced osteolysis
|
Yuan, Guixin
|
|
2019
|
443 |
C |
p. 135-144
|
artikel
|
| 14 |
PLK4 is a determinant of temozolomide sensitivity through phosphorylation of IKBKE in glioblastoma
|
Zhang, Zuoxin
|
|
2019
|
443 |
C |
p. 91-107
|
artikel
|
| 15 |
The long intergenic non-protein coding RNA 707 promotes proliferation and metastasis of gastric cancer by interacting with mRNA stabilizing protein HuR
|
Xie, Min
|
|
2019
|
443 |
C |
p. 67-79
|
artikel
|
| 16 |
The membrane tethered matrix metalloproteinase MT1-MMP triggers an outside-in DNA damage response that impacts chemo- and radiotherapy responses of breast cancer
|
Thakur, Varsha
|
|
2019
|
443 |
C |
p. 115-124
|
artikel
|
| 17 |
The role of miR-183 cluster in immunity
|
Ichiyama, Kenji
|
|
2019
|
443 |
C |
p. 108-114
|
artikel
|
| 18 |
Triptonide inhibits human nasopharyngeal carcinoma cell growth via disrupting Lnc-RNA THOR-IGF2BP1 signaling
|
Wang, Shu-sheng
|
|
2019
|
443 |
C |
p. 13-24
|
artikel
|
| 19 |
Ubiquitin-protein ligase E3C maintains non-small-cell lung cancer stemness by targeting AHNAK-p53 complex
|
Gu, Jie
|
|
2019
|
443 |
C |
p. 125-134
|
artikel
|
Tijdschrift beschrijving